RITUXAN Side Effects

7023561-5 | Brown-sequard Syndrome
on Sep 22, 2010 Male patient from CANADA , 63 years of age, weighting 200.0 lb, was diagnosed with lymphoplasmacytoid lymphoma/immunocytoma and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: brown-sequard syndrome. Rituxan dosage: 375 Mg/m2, Q3m. During the same period patient was treated with FLUDARABINE (Unk) (View Fludarabine Review and Fludarabine Label ). Patient was hospitalized.

7021474-6 | Cystitis Haemorrhagic
Patient was taking Rituxan (View Usage). Patient had the following side effects: cystitis haemorrhagic on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 141.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Rituxan dosage: 1000 Mg, Q6m. During the same period patient was treated with ADDERALL 10 (View Adderall 10 Review and Adderall 10 Label ).

7019519-2 | Small Intestinal Perforation
Adverse event was reported on Sep 20, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 1000 Mg, Days 1+15) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 286.0 lb, After Rituxan was administered, patient had the following side effects: small intestinal perforation. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), ZOLOFT (Unk) (View Zoloft Review and Zoloft Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), VERAPAMIL (Unk) (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

7018702-X |
on Sep 17, 2010 Female patient from UNITED STATES , weighting 99.98 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). . Rituxan dosage: Unk.


7013933-7 | Cytokine Release Syndrome, Platelet Count Decreased
on Sep 16, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with castleman's disease and was treated with Rituxan (View Usage). Patient had the following side effects: cytokine release syndrome, platelet count decreased. Rituxan dosage: 375 Unk, Unk. Patient was hospitalized.

7013931-3 | Abdominal Pain, Bowel Movement Irregularity
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bowel movement irregularity on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 189.0 lb, was diagnosed with chronic lymphocytic leukaemia and. Rituxan dosage: 375 Mg/m2, Unk. During the same period patient was treated with VINCRISTINE (2 Mg, Unk) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), LIPOSOMAL DAUNORUBICIN (View Liposomal Daunorubicin Review and Liposomal Daunorubicin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

7006633-0 | Chills, Infusion Related Reaction, Sinus Congestion, Throat Irritation
Adverse event was reported on Sep 21, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: 757mg/4wks/iv) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , weighting 187.2 lb, Patient experienced the following unwanted or unexpected effects: chills, infusion related reaction, sinus congestion, throat irritation.

7002138-1 | Cystitis
on Sep 17, 2010 Female patient from UNITED STATES , weighting 250.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient had the following side effects: cystitis. Rituxan dosage: 1,000 Mg 1 Dose X 2wks Apart, Then Q6 Months X 2 Iv. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6990112-0 | Cerebrovascular Accident, Pneumonia Aspiration
on Sep 08, 2010 Female patient from UNITED STATES , weighting 217.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: cerebrovascular accident, pneumonia aspiration. Rituxan dosage: 1000 Mg, Single. During the same period patient was treated with CYMBALTA (60 Mg, Qd) (View Cymbalta Review and Cymbalta Label ), LISINOPRIL (5 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), METHOTREXATE (12.5 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), FOLATE (1 Mg, Qd) (View Folate Review and Folate Label ), PERCOCET (View Percocet Review and Percocet Label ), PRAVASTATIN (20 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), REQUIP (0.25 Mg, Unk) (View Requip Review and Requip Label ), NORVASC (10 Mg, Qd) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6989854-2 | Abortion Spontaneous, Rheumatoid Arthritis
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, rheumatoid arthritis (What is rheumatoid arthritis?) on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypothyroidism and. Rituxan dosage: 1000 Mg, Q2w. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CYTOMEL (View Cytomel Review and Cytomel Label ).

6988486-X | Bladder Disorder, Mucosal Exfoliation
Adverse event was reported on Sep 08, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 141.0 lb, Patient had the following side effects: bladder disorder, mucosal exfoliation.

6986101-2 | Acarodermatitis, Alopecia
on Sep 07, 2010 Female patient from UNITED STATES , 85 years of age, was diagnosed with chronic leukaemia and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: acarodermatitis, alopecia. Rituxan dosage: . Patient was hospitalized.

6971552-2 | Cystitis Haemorrhagic
on Aug 31, 2010 Female patient from UNITED STATES , weighting 141.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis haemorrhagic. Rituxan dosage: 1000 Mg, Q2w. During the same period patient was treated with ADDERALL 10 (View Adderall 10 Review and Adderall 10 Label ).

6961655-0 | Clostridial Infection, Decubitus Ulcer, Guillain-barre Syndrome, Mucocutaneous Rash, Neuropathy Peripheral, Neurotoxicity, Sepsis
Patient was taking Rituxan (View Usage). Patient had the following side effects: clostridial infection, decubitus ulcer, guillain-barre syndrome (What is guillain-barre syndrome?), mucocutaneous rash, neuropathy peripheral, neurotoxicity, sepsis (What is sepsis?) on Aug 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 103.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and. Rituxan dosage: . During the same period patient was treated with VELCADE (1.6 Mg/m2, Unk) (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6943567-1 | Cerebral Toxoplasmosis, Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Aug 18, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 63 years of age, After Rituxan was administered, patient had the following side effects: cerebral toxoplasmosis, progressive multifocal leukoencephalopathy. During the same period patient was treated with FLUDARABINE (View Fludarabine Review and Fludarabine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6941605-3 | Intestinal Perforation
on Aug 17, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal perforation. Rituxan dosage: Unk.

6934711-0 | Cellulitis, Convulsion, Cough, Dementia, Ecchymosis, Fall, Restless Legs Syndrome
on Aug 04, 2010 Male patient from UNITED KINGDOM , weighting 218.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), convulsion, cough, dementia (What is dementia?), ecchymosis, fall (What is fall?), restless legs syndrome. Rituxan dosage: Unk. During the same period patient was treated with ACTEMRA (300 Mg, Q4w) (View Actemra Review and Actemra Label ).

6934707-9 | Enterovirus Infection, Motor Dysfunction, Quadriplegia
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: enterovirus infection, motor dysfunction, quadriplegia on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , 23 years of age, was diagnosed with thrombotic thrombocytopenic purpura and. Rituxan dosage: Unk.

6930577-3 | Encephalomyelitis, West Nile Viral Infection
Adverse event was reported on Aug 10, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: 375 Mg/m2, Unk) was diagnosed with mantle cell lymphoma and. Location: UNITED STATES , weighting 156.5 lb, Patient experienced the following unwanted or unexpected effects: encephalomyelitis, west nile viral infection. During the same period patient was treated with VELCADE (1.3 Mg/m2, Unk) (View Velcade Review and Velcade Label ), CYCLOPHOSPHAMIDE (600 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (40 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6930045-9 | Clostridial Infection, Decubitus Ulcer, Guillain-barre Syndrome, Mucocutaneous Rash, Neuropathy Peripheral, Neurotoxicity, Sepsis
on Aug 10, 2010 Female patient from UNITED STATES , weighting 103.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan (View Usage). Patient had the following side effects: clostridial infection, decubitus ulcer, guillain-barre syndrome (What is guillain-barre syndrome?), mucocutaneous rash, neuropathy peripheral, neurotoxicity, sepsis (What is sepsis?). Rituxan dosage: . During the same period patient was treated with VELCADE (1.6 Mg/m2, Unk) (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6929057-0 | Blood Bilirubin Increased, Haemolytic Anaemia, Thrombocytopenia
on Aug 10, 2010 Male patient from UNITED STATES , weighting 198.0 lb, was diagnosed with chronic lymphocytic leukaemia, non-hodgkin's lymphoma and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: blood bilirubin increased, haemolytic anaemia, thrombocytopenia. Rituxan dosage: 375 Mg/m2, Q4w. During the same period patient was treated with BENDAMUSTINE (90 Mg/m2, Qdx2) (View Bendamustine Review and Bendamustine Label ).

6925404-4 | Feeling Cold, Infusion Related Reaction, Tremor
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: feeling cold, infusion related reaction, tremor on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 197.4 lb, was diagnosed with non-hodgkin's lymphoma and. Rituxan dosage: 799mg Q 3wks Iv.

6924268-2 | Viral Titre Decreased
Adverse event was reported on Aug 09, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: Unk) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , weighting 171.0 lb, Patient had the following side effects: viral titre decreased. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ).

6920138-4 | Lymphopenia, Serum Sickness-like Reaction
on Aug 05, 2010 Female patient from UNITED STATES , weighting 213.8 lb, was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: lymphopenia, serum sickness-like reaction. Rituxan dosage: 750 Mg, 1/week. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), IMITREX (View Imitrex Review and Imitrex Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ATIVAN (View Ativan Review and Ativan Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6919020-8 | Abdominal Distension, Chills, Flushing, Hypotension
on Aug 03, 2010 Male patient from UNITED STATES , weighting 201.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, chills, flushing, hypotension. Rituxan dosage: 800 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6909440-X | Leukoencephalopathy
Patient was taking Rituxan (View Usage). Patient had the following side effects: leukoencephalopathy on Jul 28, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 87 years of age, was diagnosed with b-cell lymphoma and. Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6902136-X | Inflammation
Adverse event was reported on Jul 29, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 250 Mg/m2, Single) was diagnosed with b-cell lymphoma, constipation (What is constipation?), infection prophylaxis and. Location: JAPAN , 61 years of age, After Rituxan was administered, patient had the following side effects: inflammation. During the same period patient was treated with ZEVALIN (130 Mbq, Unk) (View Zevalin Review and Zevalin Label ), MAGMITT (1980 Mg, Qd) (View Magmitt Review and Magmitt Label ), COTRIM (1 Tablet, Qd) (View Cotrim Review and Cotrim Label ), ZYLORIC (200 Mg, Qd) (View Zyloric Review and Zyloric Label ), GASTER (200 Mg, Qd) (View Gaster Review and Gaster Label ). Patient was hospitalized.

6901300-3 | Clostridial Infection, Decubitus Ulcer, Guillain-barre Syndrome, Mucocutaneous Rash, Neuropathy Peripheral, Neurotoxicity, Sepsis
on Jul 26, 2010 Female patient from UNITED STATES , weighting 103.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, decubitus ulcer, guillain-barre syndrome (What is guillain-barre syndrome?), mucocutaneous rash, neuropathy peripheral, neurotoxicity, sepsis (What is sepsis?). Rituxan dosage: . During the same period patient was treated with VELCADE (1.6 Mg/m2, Unk) (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6886861-5 | Blood Pressure Systolic Increased, Feeling Cold, Headache, Infusion Related Reaction, Tremor
on Jul 29, 2010 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan (View Usage). Patient had the following side effects: blood pressure systolic increased, feeling cold, headache (What is headache?), infusion related reaction, tremor. Rituxan dosage: 700 D1+15 Q 4wk X4 Cycles Iv.

6886764-6 | Chills, Dyspnoea, Heart Rate Increased, Infusion Related Reaction, Oxygen Saturation Decreased, Tremor
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: chills, dyspnoea, heart rate increased, infusion related reaction, oxygen saturation decreased, tremor on Jul 29, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 195.0 lb, was diagnosed with lymphocytic lymphoma and. Rituxan dosage: 800 Weekly Iv.

6885283-0 | Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Jul 29, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 375mg/m2 Once Iv, Given Once In June 2010) was diagnosed with anaemia haemolytic autoimmune and. Location: UNITED STATES , 31 years of age, weighting 222.7 lb, Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy.

6876952-7 | Viral Titre Decreased
on Jul 19, 2010 Female patient from UNITED STATES , weighting 171.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). Patient had the following side effects: viral titre decreased. Rituxan dosage: Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ).

6876871-6 | Aphasia, Convulsion, Hallucination, Infusion Related Reaction, Loss Of Consciousness
on Jul 20, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: aphasia (What is aphasia?), convulsion, hallucination, infusion related reaction, loss of consciousness. Rituxan dosage: 1000 Mg, Unk.

6874410-7 | Cough, Dyspnoea, Flushing, Infusion Related Reaction, Oropharyngeal Pain
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, flushing, infusion related reaction, oropharyngeal pain on Jul 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 253.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Rituxan dosage: 1000mg Twice Q 6 Mos. Iv Rxn Appeared 1h35mg After Infusion Began.

6871594-1 | Blood Bilirubin Increased, Haemolytic Anaemia, Pulmonary Haemorrhage
Adverse event was reported on Jul 16, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: 375 Mg/m2, Single) was diagnosed with chronic lymphocytic leukaemia, non-hodgkin's lymphoma and. Location: UNITED STATES , 76 years of age, Patient had the following side effects: blood bilirubin increased, haemolytic anaemia, pulmonary haemorrhage. During the same period patient was treated with BENDAMUSTINE (90 Mg/m2, Qdx2) (View Bendamustine Review and Bendamustine Label ).

6869500-9 | Anaemia, Hernia, Large Intestine Perforation, Neuropathy Peripheral, Sinusitis
on Jul 15, 2010 Female patient from UNITED STATES , weighting 210.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: anaemia, hernia (What is hernia?), large intestine perforation, neuropathy peripheral, sinusitis (What is sinusitis?). Rituxan dosage: 1 G, Days 1+15. During the same period patient was treated with LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ), HYDRALAZINE HCL (50 Mg, Qd) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ), PRILOSEC (20 Mg, Qd) (View Prilosec Review and Prilosec Label ), K+10 (10 Meq, Qd) (View K+10 Review and K+10 Label ), ZOCOR (10 Mg, Qd) (View Zocor Review and Zocor Label ), BENADRYL (25 Mg, Prn) (View Benadryl Review and Benadryl Label ), CLONIDINE (0.1 Mg, Bid) (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6863439-0 | Progressive Multifocal Leukoencephalopathy
on Jul 15, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Rituxan dosage: Unk.

6863131-2 | Abscess, Cerebrovascular Accident, Hernia
Patient was taking Rituxan (View Usage). Patient had the following side effects: abscess (What is abscess?), cerebrovascular accident, hernia (What is hernia?) on Jul 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 254.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Rituxan dosage: Unk. During the same period patient was treated with DIAZEPAM (5 Mg, Tid) (View Diazepam Review and Diazepam Label ), SINGULAIR (View Singulair Review and Singulair Label ), MUCINEX D (View Mucinex D Review and Mucinex D Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), NASONEX (View Nasonex Review and Nasonex Label ), DUONEB (View Duoneb Review and Duoneb Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ).

6861287-9 | Haematocrit Decreased, Platelet Count Increased
Adverse event was reported on Jul 13, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 670 Mg, 1/week X3) was diagnosed with idiopathic thrombocytopenic purpura and. Location: UNITED STATES , weighting 229.3 lb, After Rituxan was administered, patient had the following side effects: haematocrit decreased, platelet count increased. During the same period patient was treated with PREDNISONE (10 Mg, Unk) (View Prednisone Review and Prednisone Label ), CELEXA (View Celexa Review and Celexa Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6858883-1 | Progressive Multifocal Leukoencephalopathy
on Jun 23, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with idiopathic thrombocytopenic purpura, lupus-like syndrome, autoimmune thrombocytopenia, arthralgia and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Rituxan dosage: 375/m2, Unk. During the same period patient was treated with PREDNISONE (60 Mg, Unk) (View Prednisone Review and Prednisone Label ), IMURAN (200 Unk, Bid) (View Imuran Review and Imuran Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ). Patient was hospitalized.

6858580-2 | Organising Pneumonia, Pancytopenia
on Jul 05, 2010 Male patient from UNITED KINGDOM , 55 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan (View Usage). Patient had the following side effects: organising pneumonia, pancytopenia. Rituxan dosage: 375 Mg/m2, 1/week. During the same period patient was treated with DEXAMETHASONE (200 Mg/m2, Qam) (View Dexamethasone Review and Dexamethasone Label ), METHYLPREDNISOLONE (1000 Mg/m2, Qam) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6857599-5 | Convulsion
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: convulsion on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 158.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Rituxan dosage: . During the same period patient was treated with ACTEMRA (320 Mg, Q4w) (View Actemra Review and Actemra Label ), MTX (12.5 Unk, Unk) (View Mtx Review and Mtx Label ).

6846131-8 | Liver Disorder, Pneumonia
Adverse event was reported on Jul 09, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 250 Mg/m2, Single) was diagnosed with b-cell lymphoma and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder, pneumonia (What is pneumonia?). During the same period patient was treated with ZEVALIN (14.8 Mgq/kg, Unk) (View Zevalin Review and Zevalin Label ), POLARAMINE (2 Mg, Single) (View Polaramine Review and Polaramine Label ), LOXONIN (60 Mg, Single) (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6844653-7 | Paralysis, Urinary Tract Infection
on Jul 07, 2010 Female patient from UNITED STATES , weighting 130.3 lb, was diagnosed with neuromyelitis optica, blood pressure increased and was treated with Rituxan (View Usage). Patient had the following side effects: paralysis (What is paralysis?), urinary tract infection (What is urinary tract infection?). Rituxan dosage: Unk. During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MACROBID (View Macrobid Review and Macrobid Label ), ATIVAN (View Ativan Review and Ativan Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ). Patient was hospitalized.

6840668-3 | Body Temperature Increased, Myalgia, Pain
on Jul 13, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: body temperature increased, myalgia, pain (What is pain?). Rituxan dosage: 700 Mg Iv. Patient was hospitalized.

6836728-3 | Cerebrovascular Accident, Pneumonia Aspiration
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, pneumonia aspiration on Jul 07, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 217.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Rituxan dosage: 1000 Mg, Single. During the same period patient was treated with CYMBALTA (60 Mg, Qd) (View Cymbalta Review and Cymbalta Label ), LISINOPRIL (5 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), METHOTREXATE (12.5 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), FOLATE (1 Mg, Unk) (View Folate Review and Folate Label ), PERCOCET (View Percocet Review and Percocet Label ), PRAVASTATIN (20 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), REQUIP (0.5 Mg, Unk) (View Requip Review and Requip Label ), NORVASC (10 Mg, Qd) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6828435-8 | Pneumonia
Adverse event was reported on Jul 08, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 2000 Mg Every 6 Months Iv Drip) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 61 years of age, weighting 220.0 lb, Patient had the following side effects: pneumonia (What is pneumonia?). Patient was hospitalized.

6828075-0 | Chest Pain, Pulmonary Haemorrhage, Shock
on Jul 02, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: chest pain (What is chest pain?), pulmonary haemorrhage, shock. Rituxan dosage: . Patient was hospitalized.

6820701-5 | Dermatitis Allergic, Headache, Lung Infection, Mycobacterium Avium Complex Infection, Pneumonia
on Jun 29, 2010 Female patient from UNITED STATES , weighting 141.0 lb, was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis allergic, headache (What is headache?), lung infection, mycobacterium avium complex infection, pneumonia (What is pneumonia?). Rituxan dosage: Unk. Patient was hospitalized.

6815170-5 | Back Pain, Blood Pressure Increased, Dyspepsia, Dyspnoea, Erythema, Flushing, Heart Rate Increased
Patient was taking Rituxan (View Usage). Patient had the following side effects: back pain (What is back pain?), blood pressure increased, dyspepsia, dyspnoea, erythema, flushing, heart rate increased on Jun 30, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with b-cell lymphoma and. Rituxan dosage: 711mg Q3wks Iv.